Literature DB >> 18392749

Multisystem involvement in a patient due to accumulation of amylopectin-like material with diminished branching enzyme activity.

T F Eminoglu1, L Tumer, I Okur, R Olgunturk, A Hasanoglu, I I Gonul, B Dalgic.   

Abstract

We report a 13-year-old boy with multisystem involvement secondary to accumulation of amylopectin-like material. He was born to consanguineous parents at full term without any complications and his maternal perinatal history was uneventful. His parents were cousins. He had normal growth and development except for his weight. His sister died from an unexplained cardiomyopathy at the age of 8 years. Our patient's initial symptom was severe heart failure. Since he also had a complaint of muscle weakness, electromyography was performed which showed muscle involvement. The diagnosis was suggested by tissue biopsy of skeletal muscle showing intracellular, basophilic, diastase-resistant, periodic acid-Schiff-positive inclusion bodies and was confirmed by the presence of a completed branching enzyme deficiency. Similar intracytoplasmic inclusion-like bodies were also found in liver biopsy, but very few in number compared with the skeletal muscle. The patient died from an intercurrent infection. Postmortem endomyocardial biopsy revealed the same intracytoplasmic inclusions as described above affecting almost all myocardial cells. Ultrastructural examination of liver biopsy was nondiagnostic; however, myocardium showed prominent, large, intracytoplasmic deposits. Glycogen branching enzyme gene sequence was normal, and thus classical branching enzyme deficiency was excluded. Our patient represents the first molecular study performed on a patient in whom there was multiple system involvement secondary to accumulation of amylopectin-like material. We suggest that this is an as yet undefined and different phenotype of glycogen storage disease associated with multisystemic involvement.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18392749     DOI: 10.1007/s10545-008-0819-8

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  21 in total

1.  Familial cirrhosis of the liver with storage of abnormal glycogen.

Authors:  D H ANDERSEN
Journal:  Lab Invest       Date:  1956 Jan-Feb       Impact factor: 5.662

2.  Lack of an alpha-1,4-glucan: alpha-1,4-glucan 6-glycosyl transferase in a case of type IV glycogenosis.

Authors:  B I Brown; D H Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1966-08       Impact factor: 11.205

3.  A new variant of type IV glycogenosis with primary cardiac manifestation and complete branching enzyme deficiency. In vivo detection by heart muscle biopsy.

Authors:  S Nase; K P Kunze; M Sigmund; J M Schroeder; Y Shin; P Hanrath
Journal:  Eur Heart J       Date:  1995-11       Impact factor: 29.983

4.  Lysosomal glycogen storage disease with normal acid maltase.

Authors:  M J Danon; S J Oh; S DiMauro; J R Manaligod; A Eastwood; S Naidu; L H Schliselfeld
Journal:  Neurology       Date:  1981-01       Impact factor: 9.910

5.  A distinct form of adult polyglucosan body disease with massive involvement of central and peripheral neuronal processes and astrocytes: a report of four cases and a review of the occurrence of polyglucosan bodies in other conditions such as Lafora's disease and normal ageing.

Authors:  Y Robitaille; S Carpenter; G Karpati; S D DiMauro
Journal:  Brain       Date:  1980-06       Impact factor: 13.501

6.  Nervous system involvement in type IV glycogenosis.

Authors:  K R McMaster; J M Powers; G R Hennigar; H J Wohltmann; G H Farr
Journal:  Arch Pathol Lab Med       Date:  1979-03       Impact factor: 5.534

7.  Surprises of genetic engineering: a possible model of polyglucosan body disease.

Authors:  N Raben; M Danon; N Lu; E Lee; L Shliselfeld; A V Skurat; P J Roach; J C Lawrence ; O Musumeci; S Shanske; S DiMauro; P Plotz
Journal:  Neurology       Date:  2001-06-26       Impact factor: 9.910

8.  Juvenile hereditary polyglucosan body disease with complete branching enzyme deficiency (type IV glycogenosis).

Authors:  J M Schröder; R May; Y S Shin; M Sigmund; S Nase-Hüppmeier
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

9.  Clinical and laboratory findings in four patients with the non-progressive hepatic form of type IV glycogen storage disease.

Authors:  A McConkie-Rosell; C Wilson; D A Piccoli; J Boyle; T DeClue; P Kishnani; J J Shen; A Boney; B Brown; Y T Chen
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

10.  A new variant of type IV glycogenosis: deficiency of branching enzyme activity without apparent progressive liver disease.

Authors:  H L Greene; B I Brown; D T McClenathan; R M Agostini; S R Taylor
Journal:  Hepatology       Date:  1988 Mar-Apr       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.